source name	characteristics[organism]	characteristics[organism part]	characteristics[cell line]	characteristics[ancestry category]	characteristics[age]	characteristics[sex]	characteristics[disease]	characteristics[cell type]	characteristics[developmental stage]	Material Type	assay name	Technology Type	comment[file uri]	comment[fraction identifier]	comment[label]	comment[cleavage agent details]	comment[fractionation method]	comment[instrument]	comment[separation]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters].5	comment[modification parameters].6	comment[dissociation method]	comment[fragment mass tolerance]	comment[precursor mass tolerance]	comment[data file]	factor value[cell line]
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 219	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_1.raw	1	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_1.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 220	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_2.raw	2	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_2.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 221	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_3.raw	3	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_3.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 222	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_4.raw	4	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_4.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 223	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_5.raw	5	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_5.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 224	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_6.raw	6	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_6.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 225	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_7.raw	7	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_7.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 226	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_8.raw	8	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_8.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 227	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_9.raw	9	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_9.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 228	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_10.raw	10	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_10.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 229	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_11.raw	11	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_11.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 230	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_12.raw	12	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_12.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 231	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_13.raw	13	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_13.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 232	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_14.raw	14	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_14.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 233	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_15.raw	15	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_15.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 234	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_16.raw	16	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_16.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 235	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_17.raw	17	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_17.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 236	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_18.raw	18	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_18.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 237	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_19.raw	19	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_19.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 238	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_20.raw	20	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_20.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 239	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_21.raw	21	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_21.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 240	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_22.raw	22	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_22.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 241	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_23.raw	23	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_23.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 242	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_24.raw	24	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_24.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 243	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_25.raw	25	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_25.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 244	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_26.raw	26	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_26.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 245	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_27.raw	27	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_27.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 246	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_28.raw	28	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_28.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 247	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_29.raw	29	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_29.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 248	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_30.raw	30	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_30.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 249	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_31.raw	31	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_31.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 250	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_32.raw	32	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_32.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 251	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_33.raw	33	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_33.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 252	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_34.raw	34	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_34.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 253	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_35.raw	35	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_35.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 254	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_36.raw	36	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_36.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 255	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_37.raw	37	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_37.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 256	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_38.raw	38	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_38.raw	HeLa
Sample 7	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 257	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_39.raw	39	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Any N-term; AC=UNIMOD:28; TA=Q	NT=Phospho;TA=S,Y,T;MT=Variable;AC=UNIMOD:21	NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable	NT=Methyl;AC=UNIMOD:34;TA=R,K;MT=Variable	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150708_QE3_UPLC8_DBJ_QC_HELA_39frac_LysC_39.raw	HeLa
